Research Paper Volume 15, Issue 13 pp 6179—6211
ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility
Figure 10. Drug susceptibility analysis associated with ZNF765. (A) The correlation between ZNF765 and the four jointly expressed genes most associated with it was explored by GeneMANIA analysis. (B–E) Took advantage of the Kaplan-Meier plotter to analyze the relationship between the expression of these four genes and the overall survival of HCC patients. (F) Pathway analyses were studied by the GSCA Lite website. (G) We used the GSCA Lite website to display drug susceptibility with these five hub genes. (H) HCCLM3 cells transfected with the shNC or shZNF765 were treated with Docetaxel and Bleomycin for 72 h, and then, cell viability was measured. *p < 0.05; **p < 0.01; ***p < 0.001.